If you haven't signed up for a membership with us, now is the time. When you sign up for our membership or to one of our webinars, you are directly supporting our mission to educate about and advocate for psychedelic medicines. Furthermore,  your membership fees help us directly fund our advocacy campaign "Canada Supports" plus you get the benefit of connecting with others within our community and access to our networking events and webinars.

Sign up for our membership and get access to all the events below!

Become a member
Wednesday, December 1st 2021 at 4 pm PDT | 7 pm EDT on Zoom

Harm Reduction & Psychedelics

A panel of professional nurses will guide us through harm reduction principles and how they may be directly applied to psychedelic practices and therapy.

Get your tickets

The recording of this event will be made available for everyone who purchased a ticket and CPA members one week after the event. Thank you for your support

Interactive Town Hall
Wednesday, December 9th 2021 at 4 PM PST / 7 PM EST on Zoom

How mushrooms can save the world

Join our Executive Director Cory Firth as he sits down with special guests Dr. Pamela Kryskow and Paul Stamets for an intimate Q&A centred on the medicinal use of mushrooms in North America and how fungi can help the overall health of people and the planet.

Get your tickets

The recording of this event will be made available for everyone who purchased a ticket and CPA members one week after the event. Thank you for your support

Interactive Town Hall

The CPA to introduce new regulatory change to Health Canada

Canada overwhelmingly supports access to new regulations with polling numbers showcasing the need for change including, 78% of Canadians polled support or somewhat support a government that legalized psilocybin-assisted psychotherapy to improve the quality of life for terminally ill patients.

The Canadian Psychedelic Association and other experts from across Canada have been meeting with Members of Parliament, senior government officials, representatives from all parties, and national stakeholders over the past 10 months and encountered unanimous support for access to psilocybin therapy with a palliative diagnosis.

With public support at an all-time high, we are focusing on introducing evidence-informed regulations to officials at Health Canada. We come together with a group of key experts including palliative care professionals, therapists, MDs, non-profit supports, industry, medical and legal experts to communicate, petition, and deliver a regulatory framework that will transform the lives of Canadians who deserve access to medicine that can help them overcome their most debilitating mental anxieties.

Work with us, lend your support and help us create a new path for legal psilocybin-assisted therapy in Canada. #canadasupports
#psychedelicassociation

Donate to support our campaign
15,000 signatures!

Decriminalize healing plant medicines and fungi in Canada

Our petition's first go is now over! We gathered close to 15,000 signatures and the petition has been read in the House of Commons this fall. Thank you for your support!

Stay tuned for a NEW petition as we won't stop this campaign until our voices have been heard in Ottawa and across Canada.

Thank you to Chris Bennett, Paul Manly, Kirk Tousaw, Rob Laurie, Jovian Francey, Trevor Millar, and others who started this petition process!

Visit DecriminalizeNature.ca

Get more information on psychedelics and the community

Curious about psychedelics and their potential for therapeutic and health benefits? Want to get plugged into the movement locally? Visit our Resources centre for books we recommend, films to watch, a global ecosystem map, training programs, and ongoing clinical trials.

Visit our resources centre
LSd Medicine

A community united

A membership based organization, the CPA aims to foster community conversation and collaboration for individuals interested in psychedelics and their promise across Canada. The CPA will bring the brightest and best in this field together to work through some of the unique challenges these substances face as they gain the mainstream acceptance and use they deserve.

About the CPA
Support our work

Become a Friend of the CPA

Learn more